Trials / Unknown
UnknownNCT01206218
Evaluation of Customized Treatment According to BRCA1 Assessment in Patients With Advanced Gastric Cancer
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of customized treatment according to BRCA1 assessment in patients with advanced gastric cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | FLOT Regimen | FLOT Regimen: 5-fluorouracil, Oxaliplatin, Docetaxel |
| DRUG | FLO Regimen or FLOT Regimen | FLO Regimen: 5-fluorouracil, Oxaliplatin FLOT Regimen: 5-fluorouracil, Oxaliplatin, Docetaxel |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2012-10-01
- First posted
- 2010-09-21
- Last updated
- 2010-09-21
Source: ClinicalTrials.gov record NCT01206218. Inclusion in this directory is not an endorsement.